Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.47 Trillion Total Companies: 1,735
Total Market Cap (USD)
$1.47 Trillion
Companies Listed
1,735
Largest Company
Poseida Therapeutics Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 301 |
Poseida Therapeutics Inc
NASDAQ:PSTX |
$614.61 Million | $614.61 Million | USA | $9.50 | +0.00% | +0.00% | 21.37 Million |
| 302 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
$611.31 Million | $611.31 Million | USA | $5.36 | -0.19% | -3.07% | 144.36 Million |
| 303 |
Xiangxue Pharmaceutical
SHE:300147 |
$602.96 Million | CN¥4.42 Billion | China | CN¥9.46 | -0.42% | +0.11% | 196.56 Million |
| 304 |
Liaoning Chengda Biotechnology Co. Ltd. A
SHG:688739 |
$602.31 Million | CN¥4.42 Billion | China | CN¥25.68 | +1.86% | +3.05% | 46.40 Million |
| 305 |
POSEIDA THERAP. DL-0001
F:2RZ |
$600.99 Million | €585.49 Million | Germany | €9.05 | +0.00% | +0.00% | 0.00 |
| 306 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
$596.86 Million | $596.86 Million | USA | $10.44 | +0.68% | -2.16% | 25.18 Million |
| 307 |
MoonLake Immunotherapeutics
NASDAQ:MLTX |
$593.52 Million | $593.52 Million | USA | $16.73 | -2.34% | -7.82% | 28.75 Million |
| 308 |
Compass Therapeutics Inc.
NASDAQ:CMPX |
$583.12 Million | $583.12 Million | USA | $5.41 | +4.24% | -1.81% | 45.11 Million |
| 309 |
Sana Biotechnology Inc
NASDAQ:SANA |
$580.29 Million | $580.29 Million | USA | $3.27 | -2.68% | +3.81% | 54.90 Million |
| 310 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
$577.02 Million | $577.02 Million | USA | $1.61 | -4.73% | -5.85% | 60.15 Million |
| 311 |
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION |
$572.97 Million | $572.97 Million | USA | $37.17 | -0.40% | +3.45% | 5.89 Million |
| 312 |
Janux Therapeutics Inc
NASDAQ:JANX |
$569.03 Million | $569.03 Million | USA | $13.88 | +2.21% | +0.29% | 20.96 Million |
| 313 |
ABBISKO CAYMAN DL-00001
F:8ZD |
$566.33 Million | €551.72 Million | Germany | €1.31 | +4.80% | -2.24% | 79.20K |
| 314 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
$565.61 Million | $565.61 Million | USA | $24.31 | +1.72% | +3.76% | 12.15 Million |
| 315 |
Kura Oncology Inc
NASDAQ:KURA |
$565.58 Million | $565.58 Million | USA | $8.73 | +0.92% | -2.57% | 37.13 Million |
| 316 |
DNA Link Inc
KQ:127120 |
$552.71 Million | ₩809.28 Billion | Korea | ₩41100.00 | -1.91% | +3.66% | 7.88 Million |
| 317 |
Annexon Inc
NASDAQ:ANNX |
$547.93 Million | $547.93 Million | USA | $5.72 | +1.06% | +10.85% | 63.63 Million |
| 318 |
Sinocelltech Group Ltd
SHG:688520 |
$544.30 Million | CN¥3.99 Billion | China | CN¥39.40 | +0.48% | +6.23% | 51.04 Million |
| 319 |
Medincell SA
PA:MEDCL |
$543.16 Million | €529.15 Million | France | €20.98 | +3.15% | -1.59% | 2.52 Million |
| 320 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
$542.95 Million | $542.95 Million | USA | $4.36 | +2.35% | -3.75% | 63.71 Million |
| 321 |
Acrobiosystems Co.Ltd.
SHE:301080 |
$541.69 Million | CN¥3.97 Billion | China | CN¥44.33 | -1.18% | -1.49% | 86.14 Million |
| 322 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
$536.22 Million | $536.22 Million | USA | $69.26 | +0.76% | +0.12% | 3.88 Million |
| 323 |
INVENTIVA S.A.(PROM.)-01
F:6IV |
$534.90 Million | €521.10 Million | Germany | €5.14 | -4.10% | +3.52% | 26.44K |
| 324 |
Nanjing Vazyme Biotech Co Ltd
SHG:688105 |
$534.52 Million | CN¥3.92 Billion | China | CN¥20.11 | -0.15% | +1.72% | 29.29 Million |
| 325 |
IDORSIA AG
F:19T |
$532.51 Million | €518.78 Million | Germany | €3.18 | -17.19% | -16.09% | 30.70K |
| 326 |
INVENTIVA ADS/1 O.N.
F:6IVA |
$530.73 Million | €517.05 Million | Germany | €5.10 | -0.97% | +0.99% | 1.12K |
| 327 |
Oneness Biotech Co Ltd
TWO:4743 |
$528.04 Million | NT$17.47 Billion | Taiwan | NT$57.30 | +9.98% | +6.51% | 61.87 Million |
| 328 |
Opthea Ltd
NASDAQ:OPT |
$524.82 Million | $524.82 Million | USA | $3.41 | +0.00% | +0.00% | 3.02K |
| 329 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
$515.94 Million | $515.94 Million | USA | $9.87 | -1.10% | +9.91% | 32.10 Million |
| 330 |
Oxford Nanopore Technologies Limited
PINK:ONTTF |
$509.48 Million | $509.48 Million | USA | $1.28 | -5.88% | -18.47% | 44.55K |
| 331 |
D&D PharmaTech Co.
KQ:347850 |
$507.78 Million | ₩743.49 Billion | Korea | ₩87600.00 | -5.09% | +4.41% | 16.68 Million |
| 332 |
Pell Bio-Med Technology Co., Ltd.
TW:6949 |
$507.62 Million | NT$16.80 Billion | Taiwan | NT$574.00 | -0.52% | -2.88% | 6.20 Million |
| 333 |
RemeGen Co. Ltd
PINK:REGMF |
$501.91 Million | $501.91 Million | USA | $1.50 | +0.00% | +0.00% | 0.00 |
| 334 |
CStone Pharmaceuticals
PINK:CSPHF |
$497.91 Million | $497.91 Million | USA | $0.52 | +0.00% | +0.00% | 0.00 |
| 335 |
Shanghai Haohai Biological Tech Co
SHG:688366 |
$496.42 Million | CN¥3.64 Billion | China | CN¥41.86 | -0.38% | +0.12% | 15.68 Million |
| 336 |
Lifecome Biochemistry Co Ltd
SHE:002868 |
$492.57 Million | CN¥3.61 Billion | China | CN¥40.78 | +0.67% | -3.18% | 39.80 Million |
| 337 |
Bright Minds Biosciences Inc
NASDAQ:DRUG |
$484.09 Million | $484.09 Million | USA | $73.21 | +1.68% | -4.76% | 2.67 Million |
| 338 |
MiMedx Group Inc
NASDAQ:MDXG |
$483.62 Million | $483.62 Million | USA | $4.41 | +0.68% | -2.00% | 20.57 Million |
| 339 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
$482.63 Million | $482.63 Million | USA | $26.55 | +2.31% | -8.04% | 9.10 Million |
| 340 |
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488 |
$472.78 Million | CN¥3.47 Billion | China | CN¥16.03 | -4.87% | -2.73% | 190.11 Million |
| 341 |
Septerna, Inc. Common Stock
NASDAQ:SEPN |
$471.35 Million | $471.35 Million | USA | $25.14 | +0.00% | -12.65% | 7.68 Million |
| 342 |
Regulus Therapeutics Inc
NASDAQ:RGLS |
$470.59 Million | $470.59 Million | USA | $8.16 | +0.25% | +0.62% | 55.65 Million |
| 343 |
Seegene Inc
KQ:096530 |
$469.15 Million | ₩686.93 Billion | Korea | ₩22100.00 | -0.67% | -6.36% | 6.66 Million |
| 344 |
Inventiva Sa
NASDAQ:IVA |
$467.63 Million | $467.63 Million | USA | $6.08 | +1.50% | -0.82% | 7.76 Million |
| 345 |
OBiO Technology (Shanghai) Corp. Ltd. A
SHG:688238 |
$463.33 Million | CN¥3.40 Billion | China | CN¥7.58 | -1.81% | +3.41% | 251.42 Million |
| 346 |
ALPHAMAB ONCOLO.DL-000002
F:3NK |
$463.11 Million | €451.16 Million | Germany | €0.94 | +2.17% | +9.30% | 9.99K |
| 347 |
Ocugen Inc
NASDAQ:OCGN |
$461.52 Million | $461.52 Million | USA | $2.33 | -6.05% | +44.72% | 200.75 Million |
| 348 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
$458.34 Million | $458.34 Million | USA | $16.82 | -0.71% | +3.64% | 19.32 Million |
| 349 |
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
$457.13 Million | CN¥3.35 Billion | China | CN¥9.46 | +0.11% | +2.60% | 122.87 Million |
| 350 |
ADC Therapeutics SA
NYSE:ADCT |
$455.20 Million | $455.20 Million | USA | $4.22 | +2.18% | +2.68% | 21.58 Million |
| 351 |
Altimmune Inc
NASDAQ:ALT |
$450.83 Million | $450.83 Million | USA | $3.62 | +3.43% | +2.26% | 75.83 Million |
| 352 |
Guanhao Biotech Co Ltd
SHE:300238 |
$448.74 Million | CN¥3.29 Billion | China | CN¥16.48 | +2.36% | +4.04% | 137.32 Million |
| 353 |
CorMedix Inc
NASDAQ:CRMD |
$445.65 Million | $445.65 Million | USA | $6.54 | +1.40% | +1.24% | 40.21 Million |
| 354 |
Sage Therapeutics Inc
NASDAQ:SAGE |
$445.41 Million | $445.41 Million | USA | $8.68 | +0.00% | -1.03% | 85.42 Million |
| 355 |
Alto Neuroscience, Inc.
NYSE:ANRO |
$444.93 Million | $444.93 Million | USA | $24.29 | +9.12% | +17.00% | 5.79 Million |
| 356 |
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590 |
$444.00 Million | CN¥3.26 Billion | China | CN¥38.09 | -1.68% | -4.46% | 57.58 Million |
| 357 |
Pharmicell
KO:005690 |
$438.96 Million | ₩642.72 Billion | Korea | ₩16130.00 | -1.77% | +11.24% | 50.25 Million |
| 358 |
Sosei Group Corporation
PINK:SOLTF |
$432.55 Million | $432.55 Million | USA | $5.91 | +0.00% | +0.00% | 0.00 |
| 359 |
Precigen Inc
NASDAQ:PGEN |
$430.40 Million | $430.40 Million | USA | $3.51 | +0.00% | +5.72% | 99.71 Million |
| 360 |
Valneva SE
PINK:INRLF |
$430.12 Million | $430.12 Million | USA | $2.92 | -15.36% | -16.57% | 2.00K |
| 361 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
$422.88 Million | $422.88 Million | USA | $4.71 | +1.29% | +1.29% | 25.32 Million |
| 362 |
PureTech Health PLC
NASDAQ:PRTC |
$421.98 Million | $421.98 Million | USA | $16.41 | -1.38% | -2.32% | 95.07K |
| 363 |
KEMPHARM INC. DL-0001
F:1GDA |
$419.45 Million | €408.64 Million | Germany | €8.65 | -1.14% | +16.89% | 9.80K |
| 364 |
Replimune Group Inc
NASDAQ:REPL |
$419.34 Million | $419.34 Million | USA | $7.36 | +3.08% | -8.80% | 33.12 Million |
| 365 |
Medy-Tox Inc
KQ:086900 |
$417.91 Million | ₩611.91 Billion | Korea | ₩117100.00 | -0.93% | -4.72% | 1.06 Million |
| 366 |
Alpha Tau Medical Ltd
NASDAQ:DRTS |
$415.81 Million | $415.81 Million | USA | $7.25 | +1.12% | +13.10% | 6.99 Million |
| 367 |
REGULUS THER.COMPAR DL001
F:7RG0 |
$414.38 Million | €403.69 Million | Germany | €7.00 | +1.45% | -0.71% | 42.90K |
| 368 |
Baolingbao Biology Co Ltd
SHE:002286 |
$414.37 Million | CN¥3.04 Billion | China | CN¥10.78 | +6.21% | +2.08% | 462.39 Million |
| 369 |
Chongqing Genrix Biopharmaceutical Co. Ltd. A
SHG:688443 |
$413.83 Million | CN¥3.04 Billion | China | CN¥26.70 | +0.79% | +4.22% | 70.86 Million |
| 370 |
Jiangsu Bioperfectus Technologies Co Ltd
SHG:688399 |
$410.36 Million | CN¥3.01 Billion | China | CN¥63.63 | -2.05% | +9.33% | 32.69 Million |
| 371 |
Green Cross Holdings Preference Shares
KO:005257 |
$406.47 Million | ₩595.16 Billion | Korea | ₩23900.00 | -0.42% | +1.70% | 25.45K |
| 372 |
Sino BiologicalInc.
SHE:301047 |
$404.97 Million | CN¥2.97 Billion | China | CN¥72.17 | +1.39% | +1.22% | 17.95 Million |
| 373 |
Lumosa Therapeutics Co. Ltd.
TWO:6535 |
$402.75 Million | NT$13.33 Billion | Taiwan | NT$151.00 | -0.66% | -6.21% | 5.95 Million |
| 374 |
Chromadex Corp
NASDAQ:CDXC |
$400.11 Million | $400.11 Million | USA | $7.87 | +0.00% | +0.00% | 554.82K |
| 375 |
Hinova Pharmaceuticals Inc. A
SHG:688302 |
$399.12 Million | CN¥2.93 Billion | China | CN¥41.40 | -0.72% | +1.92% | 25.07 Million |
| 376 |
Prothena Corporation plc
NASDAQ:PRTA |
$397.90 Million | $397.90 Million | USA | $9.17 | -0.43% | -4.38% | 11.67 Million |
| 377 |
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871 |
$392.81 Million | CN¥2.88 Billion | China | CN¥27.02 | +7.35% | +3.68% | 242.74 Million |
| 378 |
I-Mab
NASDAQ:IMAB |
$387.37 Million | $387.37 Million | USA | $3.96 | -1.74% | +0.25% | 11.39 Million |
| 379 |
Shandong Kexing Bioproducts Co. Ltd. A
SHG:688136 |
$387.13 Million | CN¥2.84 Billion | China | CN¥29.49 | -1.34% | +2.54% | 61.71 Million |
| 380 |
EirGenix
TWO:6589 |
$386.62 Million | NT$12.79 Billion | Taiwan | NT$66.40 | +0.45% | +7.27% | 14.47 Million |
| 381 |
Sinovac Biotech Ltd
NASDAQ:SVA |
$385.02 Million | $385.02 Million | USA | $6.47 | +0.00% | +0.00% | 0.00 |
| 382 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
$382.93 Million | $382.93 Million | USA | $3.67 | +0.55% | -8.48% | 63.46 Million |
| 383 |
Pulike Biological Engineering
SHG:603566 |
$382.17 Million | CN¥2.80 Billion | China | CN¥13.84 | +0.36% | +3.67% | 101.76 Million |
| 384 |
ABIVAX Société Anonyme
PINK:AAVXF |
$377.86 Million | $377.86 Million | USA | $6.91 | +0.00% | +0.00% | 0.00 |
| 385 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
$376.66 Million | $376.66 Million | USA | $2.44 | +1.67% | +6.09% | 117.27 Million |
| 386 |
Regenxbio Inc
NASDAQ:RGNX |
$366.40 Million | $366.40 Million | USA | $8.79 | +2.57% | +1.62% | 23.87 Million |
| 387 |
Bio-Thera Solutions Ltd
SHG:688177 |
$364.33 Million | CN¥2.67 Billion | China | CN¥22.27 | -1.29% | +3.58% | 42.59 Million |
| 388 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
$360.03 Million | $360.03 Million | USA | $6.05 | -0.82% | +2.72% | 14.29 Million |
| 389 |
Vanda Pharmaceuticals Inc
NASDAQ:VNDA |
$359.97 Million | $359.97 Million | USA | $8.81 | +0.00% | +11.66% | 52.59 Million |
| 390 |
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
$356.40 Million | $356.40 Million | USA | $32.40 | -2.73% | -9.67% | 13.48 Million |
| 391 |
Concord Biotech Limited
NSE:CONCORDBIO |
$355.66 Million | ₹30.80 Billion | India | ₹1158.10 | -2.04% | -4.07% | 19.31 Million |
| 392 |
SanBio Company Limited
OTCGREY:SNBIF |
$354.45 Million | $354.45 Million | USA | $6.55 | +0.00% | +0.00% | 0.00 |
| 393 |
ChemPartner PharmaTech Co Ltd
SHE:300149 |
$352.83 Million | CN¥2.59 Billion | China | CN¥10.20 | +0.59% | -2.02% | 243.89 Million |
| 394 |
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
$351.90 Million | CN¥2.58 Billion | China | CN¥39.07 | +2.60% | +16.14% | 44.28 Million |
| 395 |
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL |
$350.92 Million | $350.92 Million | USA | $7.98 | +0.38% | -10.44% | 5.13 Million |
| 396 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
$349.40 Million | $349.40 Million | USA | $8.48 | +1.80% | +0.00% | 16.20 Million |
| 397 |
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
$347.52 Million | CN¥2.55 Billion | China | CN¥24.22 | -0.29% | -3.00% | 120.22 Million |
| 398 |
GH Research PLC
NASDAQ:GHRS |
$347.27 Million | $347.27 Million | USA | $15.11 | +1.07% | -5.15% | 4.85 Million |
| 399 |
Beijing Kawin Technology Share-holding Co Ltd
SHG:688687 |
$345.83 Million | CN¥2.54 Billion | China | CN¥20.73 | -0.38% | +0.19% | 72.80 Million |
| 400 |
Sunmax Biotechnology Co Ltd
TWO:4728 |
$342.29 Million | NT$11.33 Billion | Taiwan | NT$388.50 | -0.38% | -0.26% | 205.42K |
| 401 |
Laekna, Inc.
F:4U4 |
$341.60 Million | €332.79 Million | Germany | €1.54 | +0.00% | +15.79% | 8.87K |
| 402 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
$339.96 Million | $339.96 Million | USA | $10.15 | +0.00% | -0.49% | 35.55 Million |
| 403 |
NovaBridge Biosciences
NASDAQ:NBP |
$338.96 Million | $338.96 Million | USA | $2.90 | +2.47% | -17.14% | 17.31 Million |
| 404 |
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404 |
$338.65 Million | CN¥2.48 Billion | China | CN¥10.16 | +0.20% | +0.10% | 193.83 Million |
| 405 |
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
$333.97 Million | €325.36 Million | Germany | €18.22 | -3.70% | -8.07% | 104.46K |
| 406 |
Revance Therapeutics, Inc.
NASDAQ:RVNC |
$333.19 Million | $333.19 Million | USA | $3.65 | +0.00% | +0.00% | 0.00 |
| 407 |
Gempharmatech Co. Ltd. A
SHG:688046 |
$333.19 Million | CN¥2.44 Billion | China | CN¥15.11 | -0.92% | +2.44% | 89.55 Million |
| 408 |
Relmada Therapeutics Inc
NASDAQ:RLMD |
$330.73 Million | $330.73 Million | USA | $6.18 | +4.57% | +38.88% | 63.51 Million |
| 409 |
EirGenix Inc.
TW:6589 |
$330.01 Million | NT$10.92 Billion | Taiwan | NT$56.70 | -1.73% | -7.05% | 12.59 Million |
| 410 |
INDEX PHARM. AB AK B O.N.
F:1NP |
$327.80 Million | €319.34 Million | Germany | €2.98 | -11.44% | -25.31% | 0.00 |
| 411 |
Silence Therapeutics PLC
NASDAQ:SLN |
$326.86 Million | $326.86 Million | USA | $7.35 | +6.52% | +17.98% | 5.59 Million |
| 412 |
Gubra A/S
CO:GUBRA |
$320.41 Million | Dkr2.33 Billion | Denmark | Dkr368.80 | +0.05% | -6.82% | 942.71K |
| 413 |
Beijing Scitop Bio Tech Co Ltd
SHE:300858 |
$319.13 Million | CN¥2.34 Billion | China | CN¥16.95 | +0.59% | +1.62% | 79.45 Million |
| 414 |
Newron Pharmaceuticals SpA
SW:NWRN |
$319.05 Million | CHF292.14 Million | Switzerland | CHF16.36 | -0.49% | -7.26% | 2.21 Million |
| 415 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
$317.54 Million | $317.54 Million | USA | $7.69 | +4.06% | +9.86% | 8.26 Million |
| 416 |
Absci Corp
NASDAQ:ABSI |
$316.52 Million | $316.52 Million | USA | $2.50 | +4.60% | +5.04% | 65.40 Million |
| 417 |
Northwest Biotherapeutics Inc
OTCQB:NWBO |
$316.05 Million | $316.05 Million | USA | $0.21 | +0.00% | -8.70% | 27.63 Million |
| 418 |
Theravance Biopharma Inc
NASDAQ:TBPH |
$315.49 Million | $315.49 Million | USA | $13.93 | +1.09% | +2.65% | 19.76 Million |
| 419 |
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO |
$313.38 Million | $313.38 Million | USA | $6.57 | -1.35% | -4.09% | 18.12 Million |
| 420 |
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
$310.60 Million | CN¥2.28 Billion | China | CN¥7.20 | +0.14% | +4.35% | 182.35 Million |
| 421 |
Zhejiang Shouxiangu Pharm Co
SHG:603896 |
$307.16 Million | CN¥2.25 Billion | China | CN¥19.96 | -0.15% | -6.55% | 93.34 Million |
| 422 |
Aclaris Therapeutics Inc
NASDAQ:ACRS |
$306.72 Million | $306.72 Million | USA | $3.74 | +5.65% | +22.22% | 52.88 Million |
| 423 |
Curocell
KQ:372320 |
$305.61 Million | ₩447.47 Billion | Korea | ₩47000.00 | -3.49% | -10.98% | 2.78 Million |
| 424 |
Aurisco Pharmaceutical Co Ltd
SHG:605116 |
$305.60 Million | CN¥2.24 Billion | China | CN¥25.70 | +0.27% | +3.01% | 76.07 Million |
| 425 |
Viva Biotech Holdings
PINK:VBIZF |
$304.96 Million | $304.96 Million | USA | $0.30 | +0.00% | +0.00% | 768.00 |
| 426 |
GH RESEARCH PLC DL-025
F:1KA |
$304.35 Million | €296.50 Million | Germany | €12.70 | -3.05% | +0.00% | 2.44K |
| 427 |
Solid Biosciences LLC
NASDAQ:SLDB |
$299.30 Million | $299.30 Million | USA | $7.48 | +2.33% | +10.81% | 40.67 Million |
| 428 |
Verastem Inc
NASDAQ:VSTM |
$297.70 Million | $297.70 Million | USA | $5.81 | +3.75% | -8.93% | 38.94 Million |
| 429 |
Tomocube Inc
KQ:475960 |
$294.27 Million | ₩430.86 Billion | Korea | ₩53400.00 | -2.20% | -10.40% | 5.32 Million |
| 430 |
Phylogica Limited
MU:PH7 |
$291.84 Million | €284.31 Million | Germany | €0.62 | +0.00% | +0.00% | 0.00 |
| 431 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
$288.66 Million | $288.66 Million | USA | $3.15 | +2.27% | -11.27% | 32.80 Million |
| 432 |
Nanhua Bio Medicine Co Ltd
SHE:000504 |
$288.51 Million | CN¥2.12 Billion | China | CN¥10.31 | +2.89% | +17.03% | 80.34 Million |
| 433 |
Immix Biopharma Inc
NASDAQ:IMMX |
$288.10 Million | $288.10 Million | USA | $10.77 | +7.70% | +15.93% | 17.25 Million |
| 434 |
Medigen Vaccine Biologics
TWO:6547 |
$283.60 Million | NT$9.38 Billion | Taiwan | NT$37.00 | +0.00% | +3.50% | 42.35 Million |
| 435 |
TaiMed Biologics
TWO:4147 |
$283.20 Million | NT$9.37 Billion | Taiwan | NT$50.60 | -0.98% | -6.81% | 22.82 Million |
| 436 |
Checkpoint Therapeutics Inc
NASDAQ:CKPT |
$283.10 Million | $283.10 Million | USA | $4.26 | +0.71% | +2.40% | 46.95 Million |
| 437 |
Ginkgo Bioworks Holdings
NYSE:DNA |
$281.18 Million | $281.18 Million | USA | $6.75 | -0.74% | +3.85% | 27.12 Million |
| 438 |
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
$278.86 Million | CN¥2.05 Billion | China | CN¥37.61 | -0.42% | -0.56% | 33.06 Million |
| 439 |
Takara Bio Inc
F:TF2 |
$278.76 Million | €271.57 Million | Germany | €6.05 | +0.00% | +0.00% | 13.17K |
| 440 |
Monopar Therapeutics Inc
NASDAQ:MNPR |
$278.75 Million | $278.75 Million | USA | $61.53 | +1.94% | +6.80% | 4.68 Million |
| 441 |
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM |
$277.98 Million | $277.98 Million | USA | $13.37 | +2.85% | -3.67% | 5.33 Million |
| 442 |
Shanghai Shen Lian Biomedical Corp
SHG:688098 |
$277.19 Million | CN¥2.03 Billion | China | CN¥9.01 | +0.00% | +0.45% | 79.68 Million |
| 443 |
SillaJen Inc
KQ:215600 |
$276.74 Million | ₩405.20 Billion | Korea | ₩3395.00 | -0.59% | -1.88% | 28.75 Million |
| 444 |
Eupraxia Pharmaceuticals Inc. Common Stock
NASDAQ:EPRX |
$275.84 Million | $275.84 Million | USA | $7.39 | +0.41% | -7.51% | 6.60 Million |
| 445 |
Upstream Bio, Inc.
NASDAQ:UPB |
$275.46 Million | $275.46 Million | USA | $9.61 | +4.12% | +25.46% | 52.83 Million |
| 446 |
Lineage Cell Therapeutics Inc
NYSE MKT:LCTX |
$274.26 Million | $274.26 Million | USA | $1.60 | -0.62% | -13.51% | 29.72 Million |
| 447 |
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653 |
$272.61 Million | CN¥2.00 Billion | China | CN¥20.34 | +0.15% | +1.19% | 43.12 Million |
| 448 |
PYC Therapeutics Ltd
AU:PYC |
$271.46 Million | AU$438.41 Million | Australia | AU$1.40 | -1.06% | -6.67% | 31.81 Million |
| 449 |
Genomictree Inc.
KQ:228760 |
$271.31 Million | ₩397.25 Billion | Korea | ₩19660.00 | -2.91% | +2.61% | 4.05 Million |
| 450 |
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
$269.29 Million | CN¥1.98 Billion | China | CN¥64.59 | -0.39% | -2.42% | 42.61 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries